EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 123 filers reported holding EPIZYME INC in Q1 2019. The put-call ratio across all filers is 1.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $43,000 | -72.8% | 37,251 | -41.0% | 0.00% | – |
| Q4 2021 | $158,000 | -17.3% | 63,127 | +69.5% | 0.00% | – |
| Q3 2021 | $191,000 | -38.4% | 37,251 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $310,000 | +10.7% | 37,251 | +15.9% | 0.00% | 0.0% |
| Q1 2021 | $280,000 | -19.8% | 32,136 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $349,000 | -8.9% | 32,136 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $383,000 | -25.8% | 32,136 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $516,000 | +5.3% | 32,136 | +1.6% | 0.00% | 0.0% |
| Q1 2020 | $490,000 | -17.2% | 31,619 | +31.4% | 0.00% | 0.0% |
| Q4 2019 | $592,000 | +140.7% | 24,069 | +0.9% | 0.00% | 0.0% |
| Q3 2019 | $246,000 | -17.7% | 23,859 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $299,000 | +4.9% | 23,859 | +3.7% | 0.00% | 0.0% |
| Q1 2019 | $285,000 | +100.7% | 23,009 | 0.0% | 0.00% | – |
| Q4 2018 | $142,000 | -41.8% | 23,009 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $244,000 | -21.8% | 23,009 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $312,000 | -23.0% | 23,009 | +0.8% | 0.00% | 0.0% |
| Q1 2018 | $405,000 | +65.3% | 22,829 | +16.8% | 0.00% | 0.0% |
| Q4 2017 | $245,000 | -34.1% | 19,542 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $372,000 | +26.1% | 19,542 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $295,000 | +12.2% | 19,542 | +27.3% | 0.00% | 0.0% |
| Q1 2017 | $263,000 | +41.4% | 15,347 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $186,000 | +23.2% | 15,347 | 0.0% | 0.00% | – |
| Q3 2016 | $151,000 | -3.8% | 15,347 | 0.0% | 0.00% | – |
| Q2 2016 | $157,000 | -2.5% | 15,347 | +15.9% | 0.00% | -100.0% |
| Q1 2016 | $161,000 | -24.1% | 13,245 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $212,000 | +35.0% | 13,245 | +8.8% | 0.00% | 0.0% |
| Q3 2015 | $157,000 | -42.3% | 12,174 | +7.2% | 0.00% | 0.0% |
| Q2 2015 | $272,000 | +36.0% | 11,354 | +6.8% | 0.00% | 0.0% |
| Q1 2015 | $200,000 | +2.6% | 10,628 | +2.9% | 0.00% | 0.0% |
| Q4 2014 | $195,000 | -30.4% | 10,329 | +0.1% | 0.00% | 0.0% |
| Q3 2014 | $280,000 | -12.8% | 10,319 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $321,000 | – | 10,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |